These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 34149016)
1. Substance Use Disorders and Diabetes Care: Lessons From New York Health Homes. Forthal S; Choi S; Yerneni R; Zhang Z; Siscovick D; Egorova N; Mijanovich T; Mayer V; Neighbors C Med Care; 2021 Oct; 59(10):881-887. PubMed ID: 34149016 [TBL] [Abstract][Full Text] [Related]
2. Effects of Medicaid Health Homes among people with substance use disorder and another chronic condition on health care utilization and spending: Lessons from New York State. Neighbors CJ; Choi S; Yerneni R; Forthal S; Morgenstern J J Subst Abuse Treat; 2022 Jan; 132():108503. PubMed ID: 34098212 [TBL] [Abstract][Full Text] [Related]
3. Performance Metrics of Substance Use Disorder Care Among Medicaid Enrollees in New York, New York. Alegría M; Falgas-Bague I; Fukuda M; Zhen-Duan J; Weaver C; O'Malley I; Layton T; Wallace J; Zhang L; Markle S; Neighbors C; Lincourt P; Hussain S; Manseau M; Stein BD; Rigotti N; Wakeman S; Kane M; Evins AE; McGuire T JAMA Health Forum; 2022 Jul; 3(7):e221771. PubMed ID: 35977217 [TBL] [Abstract][Full Text] [Related]
4. Medical complications associated with substance use disorders in patients with type 2 diabetes and hypertension: electronic health record findings. Winhusen T; Theobald J; Kaelber DC; Lewis D Addiction; 2019 Aug; 114(8):1462-1470. PubMed ID: 30851217 [TBL] [Abstract][Full Text] [Related]
5. Polysubstance use and association with opioid use disorder treatment in the US Veterans Health Administration. Lin LA; Bohnert ASB; Blow FC; Gordon AJ; Ignacio RV; Kim HM; Ilgen MA Addiction; 2021 Jan; 116(1):96-104. PubMed ID: 32428386 [TBL] [Abstract][Full Text] [Related]
6. Ensuring access to high-quality substance use disorder treatment for Medicaid enrollees: A qualitative study of diverse stakeholders' perspectives. Zhen-Duan J; Fukuda M; DeJonckheere M; Falgas-Bagué I; Miyawaki S; Khazi P; Alegría M J Subst Abuse Treat; 2021 Oct; 129():108511. PubMed ID: 34176694 [TBL] [Abstract][Full Text] [Related]
7. Inpatient Addiction Medicine Consultation and Post-Hospital Substance Use Disorder Treatment Engagement: a Propensity-Matched Analysis. Englander H; Dobbertin K; Lind BK; Nicolaidis C; Graven P; Dorfman C; Korthuis PT J Gen Intern Med; 2019 Dec; 34(12):2796-2803. PubMed ID: 31410816 [TBL] [Abstract][Full Text] [Related]
8. Untreated substance use disorder affects glycemic control: Results in patients with type 2 diabetes served within a network of community-based healthcare centers in Florida. Horigian VE; Schmidt RD; Duan R; Parras D; Chung-Bridges K; Batycki JN; Espinoza K; Taghioff P; Gonzalez S; Davis C; Feaster DJ Front Public Health; 2023; 11():1122455. PubMed ID: 37006591 [TBL] [Abstract][Full Text] [Related]
9. HIV testing among people with and without substance use disorder in emergency departments: A nationwide cohort study. Kimmel SD; Anderson ES; Larochelle MR Am J Emerg Med; 2021 Oct; 48():269-272. PubMed ID: 34015610 [TBL] [Abstract][Full Text] [Related]
10. Cross-national patterns of substance use disorder treatment and associations with mental disorder comorbidity in the WHO World Mental Health Surveys. Harris MG; Bharat C; Glantz MD; Sampson NA; Al-Hamzawi A; Alonso J; Bruffaerts R; Caldas de Almeida JM; Cia AH; de Girolamo G; Florescu S; Gureje O; Haro JM; Hinkov H; Karam EG; Karam G; Lee S; Lépine JP; Levinson D; Makanjuola V; McGrath J; Mneimneh Z; Navarro-Mateu F; Piazza M; Posada-Villa J; Rapsey C; Tachimori H; Ten Have M; Torres Y; Viana MC; Chatterji S; Zaslavsky AM; Kessler RC; Degenhardt L; Addiction; 2019 Aug; 114(8):1446-1459. PubMed ID: 30835879 [TBL] [Abstract][Full Text] [Related]
11. Functional and structural social support, substance use and sexual orientation from a nationally representative sample of US adults. Kahle EM; Veliz P; McCabe SE; Boyd CJ Addiction; 2020 Mar; 115(3):546-558. PubMed ID: 31599027 [TBL] [Abstract][Full Text] [Related]
12. Effects of comorbid substance use disorders on outcomes in a Housing First intervention for homeless people with mental illness. Urbanoski K; Veldhuizen S; Krausz M; Schutz C; Somers JM; Kirst M; Fleury MJ; Stergiopoulos V; Patterson M; Strehlau V; Goering P Addiction; 2018 Jan; 113(1):137-145. PubMed ID: 28667822 [TBL] [Abstract][Full Text] [Related]
13. Depression care among depressed adults with and without comorbid substance use disorders in the United States. Han B; Olfson M; Mojtabai R Depress Anxiety; 2017 Mar; 34(3):291-300. PubMed ID: 28152244 [TBL] [Abstract][Full Text] [Related]
14. Improved access and quality of care after enrollment in the New York State Children's Health Insurance Program (SCHIP). Szilagyi PG; Dick AW; Klein JD; Shone LP; Zwanziger J; McInerny T Pediatrics; 2004 May; 113(5):e395-404. PubMed ID: 15121980 [TBL] [Abstract][Full Text] [Related]
15. Impact of New York State's Health Home program on access to care among patients with diabetes. Mayer V; Mijanovich T; Egorova N; Flory J; Mushlin A; Calvo M; Deshpande R; Siscovick D BMJ Open Diabetes Res Care; 2021 Dec; 9(Suppl 1):. PubMed ID: 34933873 [TBL] [Abstract][Full Text] [Related]
16. Quality of Diabetes Care for Individuals with Comorbid Chronic Psychotic Illness: A Sex-Based Analysis. Barker LC; Kurdyak P; Jacob B; Vigod SN J Womens Health (Larchmt); 2018 Mar; 27(3):290-296. PubMed ID: 29211592 [TBL] [Abstract][Full Text] [Related]
17. Comparing Rates of Undiagnosed Hypertension and Diabetes in Patients With and Without Substance Use Disorders. Lindenfeld Z; Chen K; Kapur S; Chang JE J Gen Intern Med; 2024 Jul; 39(9):1632-1641. PubMed ID: 38467919 [TBL] [Abstract][Full Text] [Related]
18. Impact of supportive housing on substance use-related health care utilization among homeless persons who are active substance users. Miller-Archie SA; Walters SC; Singh TP; Lim S Ann Epidemiol; 2019 Apr; 32():1-6.e1. PubMed ID: 30846275 [TBL] [Abstract][Full Text] [Related]
19. Attention Deficit/Hyperactivity Disorder and Global Severity Profiles in Treatment-Seeking Patients with Substance Use Disorders. Icick R; Moggi F; Slobodin O; Dom G; Mathys F; van den Brink W; Levin FR; Blankers M; Kaye S; Demetrovics Z; van de Glind G; Velez-Pastrana MC; Schellekens ASA; Eur Addict Res; 2020; 26(4-5):201-210. PubMed ID: 32570249 [TBL] [Abstract][Full Text] [Related]
20. Prescription contraception use and adherence by women with substance use disorders. Griffith G; Kumaraswami T; Chrysanthopoulou SA; Mattocks KM; Clark RE Addiction; 2017 Sep; 112(9):1638-1646. PubMed ID: 28387979 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]